Introduction Presently, many instruments exist for assessing both patient and surgeon-based satisfaction after joint replacement, including both generic and disease specific measures. Our aim was to derive and assess the validity of a reduced function scale of the WOMAC for patients with osteoarthritis of the hip and knee.

Methods All unilateral data from 12 centres world-wide (UK, US, Canada and Australia) involved in an international, multi-centre outcome study for patients undergoing TKR were included for analysis. The reduced scale was derived from pre-operative and three month postoperative data using a combination of data-driven analysis and purely clinical methods. The reduced WOMAC was then extensively validated in three key areas; validity, reliability and responsiveness using 12 month post-operative data from the study and data from the Medicare Hip Replacement Study. Data from 898 patients pre-operatively and 806 patients at three months was used for the data driven section of analysis. For the clinical section, 30 members of the orthopaedic community were surveyed as to their opinions of which items should be retained in the reduced version of the scale. These results were then combined to produce a reduced function scale of seven items to be used in conjunction with the five item pain scale. This reduced scale was then scrutinised to ensure it’s validity (both construct and content), reliability (both internal consistency and reproducibility) and responsiveness (using Standardised Response Means).

Results The items retained were: ascending stairs, rising from sitting, getting in/out of car, going shopping, rising from bed, taking off socks and sitting. The scales’s construct validity was confirmed by significant positive correlation with the SF-36 physical component score, the knee society function score, the Oxford knee score, and for the hip data, the Harris Hip Score and SF-12 physical component score. Cronbach’s alpha was consistently high (a> 0.85) with the reduced scale, showing it to be reliable.

Conclusions The SRM’s indicated that the reduced scale may even be better at detecting change than the full scale.

Introduction Using a new surgical technique for the first time involves a ‘learning curve’. The aim of this study is to assess the technical errors encountered in the early utilisation of a computer assistance system during total knee arthroplasty and to see if this error rate decreases with experience.

Methods Thirty-two total knee replacement procedures performed by a single surgeon using the Stryker Knee Navigation system for the first time, were monitored. All technical difficulties were documented. We compared the complications encountered in the first five cases against the following 27 cases.

Results Technical difficulties related to the navigation equipment were noted in four of the 32 cases (12.5%). These included (one case each); errors in tibial pin placement, concern over initial navigation readings, pin loosening, and dropping the navigation shim plate. There was a significant decrease in technical difficulties encountered in the later cases (7%) compared to the first five cases (40 percent, p= 0.041). Additionally, in three of the 32 cases (9%) the surgeon used their clinical judgement to override the navigation readings and recut the bone, to take ligament balancing into account.

Conclusions A steep learning curve is involved when first utilising the Stryker Knee Navigation system. It is recommended that adequate training is undertaken prior to utilising knee navigation. The computer readings should be considered carefully and clinical judgement should not be overridden.

In relation to the conduct of this study, one or more of the authors is in receipt of a research grant from a non-commercial source.

Introduction The reduced WOMAC function scale has been developed and initial validity performed. However, further validation and recommendations for the treatment of missing values is required. The aim of this study is to further assess the validity of the reduced function scale of the WOMAC and recommend a protocol for the treatment of missing values.

Method Further validation of the reduced scale was performed via a cross-over study of 100 pre-operative total joint replacement patients, each being randomised to receive either the full or reduced scale along with the pain scale, and then the alternate version upon admission. Data utilised in the development of the reduced scale was used to develop a missing value protocol, where the number of valid responses for several protocols was examined, as well as comparison of the means and standard deviations. Of the consenting 100 patients, 66 continued onto admission. The median time between administrations of the questionnaires was 14 days (range zero to 72 days).

Results There was no significant difference between pain scores for each questionnaire using the paired t-test (p=0.56). Similarly, there was no significant difference between the full and reduced function scales (p=0.65). The standard protocol for the full scale is that if there are four or more missing items, the patient’s response is invalid. But when there are one to three items missing, the average value for the sub-scale is substituted in lieu of these missing values. Examining the frequencies of valid responses, means and standard deviations when using different missing value protocols (none missing, zero or one, up to two and up to three missing), indicated that there was no substantial benefit between the ‘up to two’ missing and ‘up to three’ missing response protocols. However, for this small gain, the supposition that the completed items are representative of the missing ones rises from 29% (two of seven items) to 43% (three of seven items) should be considered unacceptable.

Conclusions The reduced WOMAC function scale has been further validated. It is proposed that where three or more responses are missing, the patients response is regarded as invalid. Where there are one or two items missing, the average value for the sub-scale is substituted in lieu of these missing values.

Our aim in this study was to determine the outcome of hip arthroplasty with regard to infection at our unit. Infection after total joint arthroplasty is a devastating complication. The MRC study in 1984 recommended using vertical laminar flow and prophylactic antibiotics to reduce infection rates. These measures are now routinely used. Between 1993 and 1996, 1727 primary total hip arthroplasties and 305 revision hip arthroplasties were performed and 1567 of the primary and 284 of the revision arthroplasties were reviewed between five and eight years after surgery by means of a postal questionnaire, telephone interview or examination of the medical records of those who had died.

Seventeen (1.08%) of the patients who underwent primary and six (2.1%) of those who underwent revision arthroplasty had a post-operative infection. Only 0.45% of patients who underwent primary arthroplasty required revision for infection.

To our knowledge this is the largest multi-surgeon audit of infection after total hip replacement in the UK. The follow-up of between five and eight years is longer than that of most comparable studies. Our study has shown that a large cohort of surgeons of varying seniority can achieve infection rates of 1% and revision rates for infection of less than 0.5%.

We report the results of seventy-six Harris Galante Porous Cups (HGP 1) in sixty-three patients treated by Total Hip Arthroplasty (THA) with a diagnosis of avascular necrosis (AVN) of the femur (grade III and IV). The cups were inserted between 1986 and 1994 and followed prospectively. Seventy hips with a follow up of more than five years (mean 7.6 years) were reviewed.

At last review the mean Harris Hip Score was 94 (standard deviation (& dcl001;) .8), preoperatively the mean had been 29 (& dcl001;14.7). Radiographically there was no evidence of acetabular migration. The revision rate of the femoral prosthesis was 8.6%, however only three stems (4.3%) were revised for loosening the rest being revised to allow down sizing of the femoral head. The revision rate for the acetabular prosthesis was 7.1%, (five cups). At the time of revision none of the cups were clinically loose and only required the liner to be changed. The complication rate was low with no deep infections or dislocations and only nine hips, (11.8%) with grade III heterotopic ossification. Survival analysis for both stem and cup at 8 years is 96.3% (confidence interval 91 – 100%), with a worst-case survival of 93.6%, (C.I 87.4 – 99.9%)

Previous studies of patients undergoing cemented THA for the treatment of advanced AVN have reported a high incidence of component loosening. This study shows good medium term results using the Harris Galante Porous cup for acetabular reconstruction with cemented femoral components for the treatment of this difficult problem.

Presently, many instruments exist for assessing both patient - and surgeon-based satisfaction after joint replacement, including both generic (measures of general health status) and disease specific measures. As such, the US PORT study (1995) recommends use of both the WOMAC and SF-36. However, this means that studies need to incorporate at least these two lengthy questionnaires into protocols, which increases the pressure on patients for both time and difficulty, but also introduces some duplication of data.

The SF-36 has been successfully reduced and validated to a 12 item questionnaire (SF-12) which can be used as a summarised generic health score. It would be of great benefit if a reduced version of the WOMAC could be derived to give a similar summarised disease-specific measurement tool.

To derive and assess the validity of a reduced function scale of the WOMAC for patients with osteoarthritis of the hip and knee.

All unilateral data from 12 centres world-wide (UK US Canada and Australia) involved in an international, multi-centre outcome study for patients undergoing TKR were included for analysis. The reduced scale was derived from pre-op and 3 month post op data using a combination of data-driven analysis and purely clinical methods. The reduced WOMAC was then extensively validated in three key areas; validity, reliability and responsiveness using 12 month post-op data from the study and data from the Medicare Hip Replacement Study.

Data from 898 patients pre-operatively and 806 patients at 3-months were used for the data driven section of analysis. For the clinical section, 30 members of the orthopaedic community were surveyed as to their opinions of which items should be retained in the reduced version of the scale. These results were then combined to produce a reduced function scale of 7 items to be used in conjunction with the 5-item pain scale. The questions remaining in the scale (and their original number in the scale) were: 2) ascending stairs, 3) rising from sitting, 6) walking on flat, 7) getting in/out of car, 9) putting on socks/stockings, 10) rising from bed and 14) sitting. This reduced scale was then scrutinised to ensure it’s validity (both construct and content), reliability (both internal consistency and reproducibility) and responsiveness (using Standardised Response Means). When examining 12 month data the reduced scale compared favourably with the full scale both overall, and when sub-divided by age, sex and country. It’s construct validity was confirmed by significant positive correlation with the SF-36 physical component score, the knee society function score, the Oxford knee score, and for the hip data, the Harris hip score and SF-12 physical component score. Cronbach’s alpha was consistently high (α> 0.85) with the reduced scale, showing it to be reliable, and the SRM’s indicated that the reduced scale may even be better at detecting change than the full scale.

This reduced WOMAC has been successfully derived and validated for use as a summarised and more practical version of the full WOMAC scale.

Patients who undergo total knee replacement (TKR)are at high risk of venous thromboembolism. Low-molecular-weight heparins (LMWH) are the most suitable chemical prophylactic agents but there are some uncertainties about their safety and effectiveness. The foot pump offers an alternative.

We randomised 229 patients undergoing primary, unilateral TKR to receive either the A-V Impulse foot pump or enoxaparin, a LMWH. Ascending venography was undertaken between the sixth and eighth postoperative day in 188 patients without knowledge of the randomisation category. The prevalence of venographic deep-vein thrombosis was 58% (57/99) in the foot-pump group and 54% (48/89) in the LMWH group which was not statistically significant. There were four cases of proximal thrombi and two of fatal pulmonary emboli in the foot-pump group and none in the LMWH group. There were fewer haemorrhagic complications and soft-tissue effects in the foot-pump group.

We conclude that the neither method provides superior prophylaxis.

Chemical prophylaxis is known to reduce the venographic prevalence of deep-vein thrombosis (DVT) after total knee replacement (TKR), but it is uncertain whether this affects the incidence of symptoms. Further analysis depends on the basic epidemiology of thromboembolic symptoms. We therefore studied the pattern of such symptoms in a consecutive series of 1000 patients with primary TKR, with particular reference to risk factors and prophylaxis.

We reviewed all the clinical records and contacted all the patients individually, noting risk factors, prophylaxis, symptomatic pulmonary embolus (PE) or DVT and its timing, death and its causes, and all complications. All the patients wore antiembolism stockings, 83% had regional anaesthesia and 33.9% had chemical prophylaxis.

One patient died from PE on the day of surgery, having had no prophylaxis giving a rate of 0.1% (95% CI 0.003% to 0.56%). Symptomatic, radiologically confirmed thromboembolism (VTE) was common with a rate of 10.6% (95% CI 8.7% to 12.5%). There was a similar incidence of VTE in those with and without chemical prophylaxis (10.1% v 10.5%, RR 0.96, NS). VTE was more common in patients with risk factors (15.1% v 9.5%, RR 1.59, p = 0.02) and tended to occur earlier in this group (median day of onset 5 v 7, p = 0.01). Chemical prophylaxis did not reduce the frequency of symptomatic thromboembolism in either those with risk factors (RR 0.81, p = 0.5) or those without them (RR 0.94, p = 0.8). Haematoma or wound dehiscence was more common in those having chemical prophylaxis (11.9% v 6.9%; RR 1.73 95% CI 1.16 to 2.60). Readmission for symptomatic, radio-logically confirmed thromboembolism involved 1.1% of patients (95% CI 0.55% to 2.1%). Four patients were readmitted with proven non-fatal PE and six with proven DVT (the latest on day 40).

Our results show that the main risk factor for thromboembolism was TKR itself; chemical prophylaxis did not reduce the incidence of symptomatic thromboembolism but gave an increased perception of side-effects. New prophylactic methods or combinations of methods are needed, with their efficacy compared by randomised controlled studies of both the clinical and the radiological effect.